These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 25266428

  • 1. Safety and effectiveness of continuous aerosolized albuterol in the non-intensive care setting.
    Kenyon CC, Fieldston ES, Luan X, Keren R, Zorc JJ.
    Pediatrics; 2014 Oct; 134(4):e976-82. PubMed ID: 25266428
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diastolic hypotension in pediatric patients with asthma receiving continuous albuterol.
    Wisecup S, Eades S, Hashmi SS, Samuels C, Mosquera RA.
    J Asthma; 2015 Sep; 52(7):693-8. PubMed ID: 25738493
    [Abstract] [Full Text] [Related]

  • 5. The effectiveness of magnesium sulfate for status asthmaticus outside the intensive care setting.
    DeSanti RL, Agasthya N, Hunter K, Hussain MJ.
    Pediatr Pulmonol; 2018 Jul; 53(7):866-871. PubMed ID: 29660840
    [Abstract] [Full Text] [Related]

  • 6. Theophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial.
    Wheeler DS, Jacobs BR, Kenreigh CA, Bean JA, Hutson TK, Brilli RJ.
    Pediatr Crit Care Med; 2005 Mar; 6(2):142-7. PubMed ID: 15730599
    [Abstract] [Full Text] [Related]

  • 7. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus.
    Bogie AL, Towne D, Luckett PM, Abramo TJ, Wiebe RA.
    Pediatr Emerg Care; 2007 Jun; 23(6):355-61. PubMed ID: 17572517
    [Abstract] [Full Text] [Related]

  • 8. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children.
    Papo MC, Frank J, Thompson AE.
    Crit Care Med; 1993 Oct; 21(10):1479-86. PubMed ID: 8403956
    [Abstract] [Full Text] [Related]

  • 9. Helium/oxygen-driven albuterol nebulization in the management of children with status asthmaticus: a randomized, placebo-controlled trial.
    Bigham MT, Jacobs BR, Monaco MA, Brilli RJ, Wells D, Conway EM, Pettinichi S, Wheeler DS.
    Pediatr Crit Care Med; 2010 May; 11(3):356-61. PubMed ID: 20464778
    [Abstract] [Full Text] [Related]

  • 10. Metabolic and electrocardiographic effects of albuterol in pediatric asthmatic patients treated in an emergency room setting.
    Del Río-Navarro B, Gazca-Aguilar A, Quibrera Matienzo JA, Rodríguez Galván Y, Sienra-Monge JJ.
    Allergol Immunopathol (Madr); 1999 May; 27(1):18-23. PubMed ID: 10217668
    [Abstract] [Full Text] [Related]

  • 11. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
    Craven D, Kercsmar CM, Myers TR, O'riordan MA, Golonka G, Moore S.
    J Pediatr; 2001 Jan; 138(1):51-58. PubMed ID: 11148512
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of continuous albuterol nebulization in children with severe status asthmaticus.
    Craig VL, Bigos D, Brilli RJ.
    Pediatr Emerg Care; 1996 Feb; 12(1):1-5. PubMed ID: 8677169
    [Abstract] [Full Text] [Related]

  • 13. High-dose continuous nebulized levalbuterol for pediatric status asthmaticus: a randomized trial.
    Andrews T, McGintee E, Mittal MK, Tyler L, Chew A, Zhang X, Pawlowski N, Zorc JJ.
    J Pediatr; 2009 Aug; 155(2):205-10.e1. PubMed ID: 19464028
    [Abstract] [Full Text] [Related]

  • 14. Safety and effectiveness of albuterol solutions with and without benzalkonium chloride when administered by continuous nebulization.
    Orth LE, Kelly BJ, Lagasse CA, Collins SW, Ryan MF.
    Am J Health Syst Pharm; 2018 Nov 15; 75(22):1791-1797. PubMed ID: 30282664
    [Abstract] [Full Text] [Related]

  • 15. An Asthma Protocol Improved Adherence to Evidence-Based Guidelines for Pediatric Subjects With Status Asthmaticus in the Emergency Department.
    Miller AG, Breslin ME, Pineda LC, Fox JW.
    Respir Care; 2015 Dec 15; 60(12):1759-64. PubMed ID: 26106203
    [Abstract] [Full Text] [Related]

  • 16. Implementing a Respiratory Therapist-Driven Continuous Albuterol Weaning Protocol in the Pediatric ICU.
    Maue DK, Tori AJ, Beardsley AL, Krupp NL, Hole AJ, Moser EA, Rowan CM.
    Respir Care; 2019 Nov 15; 64(11):1358-1365. PubMed ID: 30890627
    [Abstract] [Full Text] [Related]

  • 17. Diastolic hypotension is an unrecognized risk factor for β-agonist-associated myocardial injury in children with asthma.
    Sarnaik SM, Saladino RA, Manole M, Pitetti RA, Arora G, Kuch BA, Orr RA, Felmet KA.
    Pediatr Crit Care Med; 2013 Jul 15; 14(6):e273-9. PubMed ID: 23823208
    [Abstract] [Full Text] [Related]

  • 18. Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.
    Carroll CL, Coro M, Cowl A, Sala KA, Schramm CM.
    World J Pediatr; 2014 Nov 15; 10(4):324-9. PubMed ID: 24599614
    [Abstract] [Full Text] [Related]

  • 19. Early administration of systemic corticosteroids reduces hospital admission rates for children with moderate and severe asthma exacerbation.
    Bhogal SK, McGillivray D, Bourbeau J, Benedetti A, Bartlett S, Ducharme FM.
    Ann Emerg Med; 2012 Jul 15; 60(1):84-91.e3. PubMed ID: 22410507
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.